Preliminary unaudited results for the six months ended 30

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
126
Preliminary unaudited results for the six months ended 30 June 2017

SAN RAMON, CA --(Marketwired - September 06, 2017) - WANdisco ( LSE : WAND ) ("WANdisco", the "Company" or the "Group"), the world leader in Active Data Replication™ announces interim unaudited results for the six months ended 30 June 2017.

Financial highlights

  • Total bookings 1 for the first half of 2017 increased 73% to $10.2 million (H1 2016: $5.9 million)
    • Big Data and Cloud bookings 1 rose 173% to $7.0 million (H1 2016: $2.6 million)
    • Source Code Management ("SCM") bookings 1 stable at $3.2 million (H1 2016: $3.3 million)
    • Revenue for the period increased 71% to $9.7 million (H1 2016: $5.6 million)
    • Cash overheads 2 were reduced by $1.4 million to $11.5 million (H1 2016: $12.9 million)
    • Adjusted EBITDA 3 positive at $0.3 million (H1 2016: $4.5 million loss)
    • Statutory loss from operations reduced to $3.8 million (H1 2016: $17.9 million)
    • Cash at 30 June 2017 of $9.9 million (31 December 2016: $7.6 million)
    • Cash burn reduced to $0.6 million in H1 2017 (H1 2016: $5.3 million)
    • Debt of $3.0 million (31 December 2016: $nil)

Operational and strategic highlights

  • Increasing WANdisco Fusion ("Fusion") orders across multiple verticals achieved, with significant contract wins in the period including:
    • $4.1 million contract with a major financial services multinational
    • First contract in retail with a $2.0 million order from a major retailer
    • $0.65 million order from a US Healthcare corporation -- Fusion's first win in healthcare
    • Announced a new bank facility with Silicon Valley Bank, providing both a term debt facility and a revolving credit facility
    • Launched WANdisco Fusion 2.10, extending capabilities to Network File System devices which expands the Group's addressable market by more than $1 billion per annum
    • Fusion has adopted Oracle's Maximum Availability Architecture, increasing potential to add significant sales momentum to the existing channel partnership
    • Strong order book and second half sales pipeline underpinning medium term growth expectations

David Richards, Chief Executive Officer and Interim Chairman of WANdisco, commented:

"The first half of 2017 has been another period of significant progress for WANdisco, in which we achieved record bookings 1 , continued to reduce our cash burn and more importantly delivered a positive Adjusted EBITDA 3 . performance. This outstanding performance is down to the hard work and dedication of our team combined with increasing demand for Fusion in the Cloud and Big Data markets .

"The order book and sales pipeline continues to gather pace and our recent new business momentum demonstrates the broad appeal of Fusion across multiple verticals coupled with the excellent traction our products are receiving through our channel partners.

"Against this backdrop of positive momentum, the board has ongoing confidence for not only the second half of the year but also in our progress towards achieving profitability."

A webcast of WANdisco's results presentation will be available on the Company's website later this morning: https://www.wandisco.com/investors .

WANdisco will also be holding a presentation for private and retail investors at 16.00 p.m. on Thursday 7 September 2017 at The Dome Room, No 1 Cornhill, London, EC3V 3ND.

Admittance for the event is strictly limited to those who register their attendance in advance. For further information and to register attendance, please contact Vigo Communications via email on wandisco@vigocomms.com .

1 Bookings as defined in this press release represent the total value of all contracts received in the period including both new and renewal bookings.
2 Operating expenses, excluding amortisation and depreciation, exceptional items, equity-settled share-based payment and capitalised product development costs -- see note 5.
3 EBITDA profit/loss excluding exceptional items, equity-settled share-based payment, capitalised product development costs and acquisition-related items -- see note 5.

About WANdisco

WANdisco is the world leader in Active Data Replication™. Its patented WANdisco Fusion technology enables the replication of continuously changing data to the cloud and on-premises data centers with guaranteed consistency, no downtime and no business disruption. It also allows distributed development teams to collaborate as if they are all working in one location. WANdisco has an OEM with IBM as well as partnerships with Amazon Web Services, Cisco, Google Cloud, Hewlett Packard Enterprise, Microsoft Azure, and Oracle to resell its patented technology. WANdisco also works directly with Fortune 1000 companies around the world to ensure their data can give them the real insight they need.

For additional information, please visit www.wandisco.com .

For further information, please contact: WANdisco plc Via Vigo Communications David Richards, Chief Executive Officer and Interim Chairman Erik Miller, Chief Financial Officer Vigo Communications +44 (0)207 830 9700 Jeremy Garcia / Fiona Henson / Antonia Pollock www.vigocomms.com Stifel (Joint Broker and Nomad) +44 (0)207 710 7600 Fred Walsh / Neil Shah / Ben Maddison Peel Hunt (Joint Broker) Edward Knight / Euan Brown +44 (0)207 418 8900

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading